Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase

Current Report No. 14/2024

Date of preparation: May 28, 2024

Subject: Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase.

Legal basis: Article 56 (1) (2) of the Act on Public Offering - current and periodic information

The Management of Captor Therapeutics S.A., based in Wrocław, Poland (the "Company") announces that on 28 May 2024, the Company's Management Board adopted a resolution on the issue of 10.258 series S ordinary bearer shares, within the limits of the Company's authorized capital, excluding, in full, the pre-emptive rights of the Company's existing shareholders.

The share issue is related to the implementation of a share-based incentive programme for employees and members of the Company's bodies. The Company discloses the content of the adopted resolution.

Detailed legal basis:

§ 5 item 9 of the Ordinance of the Minister of Finance of March 29, 2018 on current and periodic information provided by issuers of securities and conditions for recognizing as equivalent information required by the laws of a non-member state)